These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12678223)

  • 1. Development of an in vitro potency test for tetanus vaccines: an immunoassay based on Hc fragment determination.
    Prieur S; Broc S; Gal M; Poirier B; Fuchs F
    Dev Biol (Basel); 2002; 111():37-46. PubMed ID: 12678223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological assays as alternatives to the Ph Eur challenge test for batch release of tetanus vaccines for human use.
    Winsnes R; Hendriksen C; Sesardic D; Akkermans A; Daas A
    Dev Biol Stand; 1999; 101():277-88. PubMed ID: 10566802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the toxin-binding inhibition (ToBI) test for the estimation of the potency of the tetanus toxoïd component in vaccines.
    van der Gun J; Akkermans A; Hendriksen C; van de Donk H
    Dev Biol Stand; 1996; 86():199-206. PubMed ID: 8785949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interlaboratory validation of in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use.
    Hendrikson CF; Woltjes J; Akkermans AM; van der Gun JW; Marsman FR; Verschure MH; Veldman K
    Dev Biol Stand; 1996; 86():335. PubMed ID: 8785975
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of tetanus toxin and toxoid by ELISA using monoclonal antibodies].
    Burkin MA; Sviridov VV; Perelygina OV
    Prikl Biokhim Mikrobiol; 2004; 40(4):478-84. PubMed ID: 15455723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and use of a novel in vitro assay for testing of diphtheria toxoid in combination vaccines.
    Coombes L; Stickings P; Tierney R; Rigsby P; Sesardic D
    J Immunol Methods; 2009 Oct; 350(1-2):142-9. PubMed ID: 19761770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive haemagglutination tests using purified antigens covalently coupled to turkey erythrocytes.
    Relyveld EH; Huet M; Lery L
    Dev Biol Stand; 1996; 86():225-41. PubMed ID: 8785953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological methods for potency testing of tetanus toxoid vaccines for human use.
    Hendriksen C; Winsnes R
    Dev Biol (Basel); 2002; 111():131-40. PubMed ID: 12678232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potency tests of diphtheria, tetanus and combined vaccines. Suggestion for a simplified potency assay.
    Aggerbeck H; Heron I
    Dev Biol Stand; 1996; 86():297-301. PubMed ID: 8785958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement of the in vivo neutralisation test for efficacy demonstration of tetanus vaccines ad us. vet.
    Rosskopf U; Noeske K; Werner E
    ALTEX; 2005; 22(3):169-74. PubMed ID: 16186992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of anti-tetanus toxoid antibody on modified polyacrylonitrile fibers.
    Jain S; Chattopadhyay S; Jackeray R; Zainul Abid CK; Kumar M; Singh H
    Talanta; 2010 Oct; 82(5):1876-83. PubMed ID: 20875591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interlaboratory validation of in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use.
    Hendriksen CF; Woltjes J; Akkermans AM; van der Gun JW; Marsman FR; Verschure MH; Veldman K
    Biologicals; 1994 Sep; 22(3):257-68. PubMed ID: 7811460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres.
    Xing DK; McLellan K; Corbel MJ; Sesardic D
    Biologicals; 1996 Mar; 24(1):57-65. PubMed ID: 8733602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaborative study for the validation of serological methods for potency testing of tetanus toxoid vaccines for human use.
    Pharmeuropa Spec Issue Biol; 2002 Oct; 2001(2):1-92. PubMed ID: 11820120
    [No Abstract]   [Full Text] [Related]  

  • 16. [In vitro immunization for the production of antibodies to tetanus toxin and toxoid. 1. Systems for the detection of in vitro synthetized specific immunoglobulins. Strategies of test development].
    Kiessig ST; Jahn S; Porstmann T; von Baehr R
    Allerg Immunol (Leipz); 1987; 33(2):79-87. PubMed ID: 2959129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of alternatives to animal tests in developing countries.
    Hong HA; Hendriks J
    Dev Biol Stand; 1999; 101():209-14. PubMed ID: 10566795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro immune response model to determine tetanus toxoid antigen (vaccine) specific immunogenicity: Selection of sensitive assay criteria.
    Piersma SJ; Leenaars MP; Guzylack-Piriou L; Summerfield A; Hendriksen CF; McCullough KC
    Vaccine; 2006 Apr; 24(16):3076-83. PubMed ID: 16504349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three enzyme-linked immunosorbent assays for detection of immunoglobulin g antibodies to tetanus toxoid with reference standards and the impact on clinical practice.
    van Hoeven KH; Dale C; Foster P; Body B
    Clin Vaccine Immunol; 2008 Dec; 15(12):1751-4. PubMed ID: 18845832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of tetanus antibodies with the aid of dot-enzyme-linked immunosorbent assay (Dot-ELISA). Validation of the results using standard ELISA and passive hemagglutination test.
    Bizzini B; Leonardi MS; Zummo S; Mastroeni P
    Boll Ist Sieroter Milan; 1990 Jun; 69(2):391-3. PubMed ID: 2152298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.